Casali Paolo Giovanni

Associate Professor
Scientific-Disciplinary Sector
MEDS-09/A - Medical Oncology
Scientific-Disciplinary Group/Competition Sector
06/MEDS-09 - MALATTIE DEL SANGUE, ONCOLOGIA E REUMATOLOGIA
Assignments
  • Vocational Master Coordinator - Coordinamento e gestione degli studi clinici (AC0)

Contacts

Workplace

Via Venezian, 1 - Istituto Nazionale Tumori
20133 MILANO (MI)

University email address
Office hours
upon appointment via email
Reception office
Fondazione IRCCS Istituto Nazionale Tumori, Milan
Teaching - Programme courses

Postgraduate programmes

A.Y. 2025/2026
1st level vocational master
A.Y. 2024/2025
Advanced course
2nd level vocational master
A.Y. 2023/2024
Advanced course
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
A.Y. 2022/2023
Advanced course
2nd level vocational master
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
Research

Publications

  • Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG) / A. Gronchi, E. Palmerini, V. Quagliuolo, J. Martin Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J. Blay, O. Tendero, R. Diaz Beveridge, V. Ferraresi, I. Lugowska, S. Pizzamiglio, P. Verderio, V. Fontana, D.M. Donati, E. Palassini, R. Sanfilippo, G. Bianchi, A. Bertuzzi, C. Morosi, S. Pasquali, S. Stacchiotti, S. Bagué, J.M. Coindre, R. Miceli, A.P. Dei Tos, P.G. Casali. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 1527-7755. - 42:8(2024), pp. 898-906. [10.1200/JCO.23.00908]
  • Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy / S. Pasquali, V. Vallacchi, L. Lalli, P. Collini, M. Barisella, C. Romagosa, S. Bague, J.M. Coindre, A.P. Dei Tos, E. Palmerini, V. Quagliuolo, J. Martin-Broto, A. Lopez-Pousa, G. Grignani, J.-. Blay, R.D. Beveridge, E. Casiraghi, S. Brich, S.L. Renne, L. Bergamaschi, B. Vergani, M. Sbaraglia, P.G. Casali, L. Rivoltini, S. Stacchiotti, A. Gronchi. - In: EBIOMEDICINE. - ISSN 2352-3964. - 106:(2024), pp. 105220.1-105220.12. [10.1016/j.ebiom.2024.105220]
  • Is rare cancer care organized at national health system level? Multiple case study in six EU countries / J. Prades, A. Trama, P.G. Casali, J. Emile, N. Gaspar, R. Janavicius, R. Jančiauskienė, S. Karjalainen, K. Kopeckova, L. Pylkkänen, M. Svoboda, J.M. Borras. - In: EUROPEAN JOURNAL OF PUBLIC HEALTH. - ISSN 1101-1262. - 32:6(2022 Dec), pp. 852-857. [10.1093/eurpub/ckac166]
  • Measuring the impact of clinical ethics support services: further points for consideration / V. Sanchini, C. Crico, P.G. Casali, G. Pravettoni. - In: JOURNAL OF MEDICAL ETHICS. - ISSN 0306-6800. - 48:11(2022 Nov), pp. 877-878. [10.1136/jme-2022-108671]
  • Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry / B. Vincenzi, A. Napolitano, A. Comandone, R. Sanfilippo, S. Celant, P.P. Olimpieri, S. Di Segni, P. Russo, P.G. Casali. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - (2022 Oct 04), pp. 1-8. [10.1002/ijc.34309]